S. Lꢀpez et al.
lenes, 50 mL, 5ꢆ10À3 mmol), tBu3P (1 mL, 4ꢆ10À3 mmol), benzyldimethyl-
silane (229 mL, 1.45 mmol), and 8 (107 mg, 1.11 mmol) in THF (2 mL) af-
forded compound 13 (284 mg, 97%).
Acknowledgements
We thank the MICINN (projects CTQ2011-28258 and Consolider Ingenio
2010 (CSD2007-00006)) for financial support. J.B. thanks the Xunta de
Galicia and MICINN for predoctoral grants.
Synthesis of (2E,4E)-5-(benzyldimethylsilyl)-5-deutero-3-methylpenta-
2,4-dien-1-ol (5-D-13): Following the general procedure, reaction of Pt-
ACHTUNGTRENNUNG
(dvds) (0.1m in xylenes, 313 mL, 3.13ꢆ10À2 mmol), tBu3P (8 mL, 3.13ꢆ
10À2 mmol), benzyldimethylsilane (744 mL, 4.70 mmol), and 5-D-8
(300 mg, 3.13 mmol) in THF (6 mL) afforded compound 5-D-13 (527 mg,
[1] a) The Retinoids: Biology, Chemistry and Medicine (Eds.: M. B.
Sporn, A. B. Roberts, D. S. Goodman), Raven, New York, 1994;
[2] a) R. Blomhoff, M. H. Green, T. Berg, K. R. Norum, Science 1990,
250, 399–404; b) J. L. Napoli in Encyclopedia of Biological Chemis-
try, Vol. 4 (Eds.: W. J. Lennarz, D. M. Lane), Elsevier, Oxford, 2004,
pp. 354–359.
Hofmann, P. Scheeerer, P. W. Hildebrand, H. Choe, J. H. Park, M.
1
96%, >95% 5-D as determined by H NMR spectroscopy).
Synthesis of (2E,4E)-5-(benzyldimethylsilyl)-4-deutero-3-methylpenta-
2,4-dien-1-ol (4-D-13): Following the general procedure, reaction of Pt-
ACHTUNGTRENNUNG
(dvds) (0.1m in xylenes, 208 mL, 2.08ꢆ10À2 mmol), tBu3P (5 mL, 2.08ꢆ
10À2 mmol), benzyldeuterodimethylsilane (494 mL, 3.12 mmol), and
8
(200 mg, 2.08 mmol) in THF (4 mL) afforded compound 4-D-13 (479 mg,
1
93%, >95% 4-D as determined by H NMR spectroscopy).
Synthesis of (2E,4E)-5-(benzyldimethylsilyl)-4,5-dideutero-3-methylpen-
ta-2,4-dien-1-ol (4,5-D2-13): Following the general procedure, reaction of
PtACHTUNGTRENNUNG
(dvds) (0.1m in xylenes, 313 mL, 3.13ꢆ10À2 mmol), tBu3P (8 mL, 3.13ꢆ
10À2 mmol), benzyldeuterodimethylsilane (744 mL, 4.70 mmol), and 5-D-8
(300 mg, 3.13 mmol) in THF (6 mL) afforded compound 4,5-D2-13
(501 mg, 91%, >95% 4,5-D2 as determined by 1H NMR spectroscopy).
[5] a) D. J. Mangelsdorf, C. Thummel, M. Beato, P. Herrlich, G. Schꢅtz,
K. Umesono, B. Blumberg, P. Kastner, M. Mark, P. Chambon, R. M.
guet, H. Gronemeyer, ꢇ. R. de Lera, Expert Opin. Ther. Pat. 2011,
21, 55–63.
General procedure for the Hiyama cross-coupling of organosilicon com-
pounds 13, 5-D-13, 4-D-13, and 4,5-D2-13 with trienyl iodide 7:
TBAF·3H2O (1.0m in THF, 2 equiv) was added dropwise to a solution of
dienyl silanes 13, 5-D-13, 4-D-13, or 4,5-D2-13 (1.5 equiv) in THF
(20 mLmmolÀ1) and the reaction was stirred for 30 min. A solution of tri-
enyl iodide 7 (1 equiv) in THF and [Pd2ACTHNUTRGNEUNG
(dba)3]·CHCl3 (5ꢆ10À2 equiv)
were sequentially added, and the reaction was stirred for 1 h. The mix-
ture was diluted with diethyl ether and filtered through a short pad of
silica gel. The solvent was removed under vacuum and the crude was pu-
rified by column chromatography (SiO2, 70:30 hexane/AcOEt) to afford
the corresponding all-trans-retinols (1, 11-D-1, 12-D-1, 11,12-D2-1) as
yellow oils.
[6] a) L. W. Spruce, J. B. Gale, K. D. Berlin, A. K. Verma, T. R. Breit-
b) W. Bollag, E. E. Holdener, Ann. Oncol. 1992, 3, 513–526;
c) D. M. Benbrook, M. M. Madler, L. W. Spruce, P. J. Brickbichler,
E. C. Nelson, S. Subramanian, G. M. Weerasekare, J. B. Gale, M. K.
Patterson, Jr., B. Wang, W. Wang, S. Lu, T. C. Rowland, P. DiSives-
trovsky, J. Natl. Canc. Inst. 2006, 98, 426–427.
[7] For significant reviews on the synthesis of retinoids, see: a) R. S. H.
ic Chemisry of Retinoids”: M. I. Dawson, P. D. Hobbs, The Reti-
noids: Biology, Chemistry and Medicine (Eds.: M. B. Sporn, A. B.
Roberts, D. S. Goodman), Raven, New York, 1994; c) B. Domꢁ-
nguez, R. Alvarez, A. R. de Lera, Org. Prep. Proced. Int. 2003, 35,
239–306; d) J. H. Barnard, J. C. Collings, A. Whiting, S. A. Prybor-
903–908; b) J. Lugtenburg, Eur. J. Clin. Nutr. 1996, 50, S17–S20;
c) J. Lugtenburg, A. F. L. Creemers, M. A. Verhoeven, A. A. C. van
Wijk, P. J. E. Verdegem, M. C. F. Monnee, F. J. H. M. Jansen, Pure
[9] a) G. Eyring, B. Curry, R. Mathies, A. Broek, J. Lugtenburg, J. Am.
Recl. Trav. Chim Pays-Bas 1980, 99, 363–366; c) A. D. Broek, J.
Lugtenburg, Recl. Trav. Chim Pays-Bas 1982, 101, 102–105; d) G.
Eyring, B. Curry, A. Broek, J. Lugtenburg, R. Mathies, Biochemistry
Winkel, J. Lugtenburg, Recl. Trav. Chim Pays-Bas 1986, 105, 92–98;
f) I. Palings, J. A. Pardoen, E. van den Berg, C. Winkel, J. Lugten-
Synthesis of trans-retinol (1): Following the general procedure, treatment
of a solution of dienylsilane 13 (31.6 mg, 9.61ꢆ10À2 mmol) in THF
(1 mL) with TBAF·3H2O (1.0m in THF, 128 mL, 0.128 mmol) for 30 min,
followed by addition of a solution of iodide 7 (20 mg, 6.43ꢆ10À2 mmol)
in THF (1 mL) and [Pd2ACHTUNGTRENNUNG
(dba)3]·CHCl3 (2 mg, 2.12ꢆ10À3 mmol), afforded
compound 1 (18 mg, 77%).
Synthesis of trans-11-deuteroretinol (11-D-1): Following the general pro-
cedure, treatment of
a solution of dienylsilane 5-D-13 (117 mg,
0.474 mmol) in THF (1 mL) with TBAF·3H2O (1.0m in THF, 632 mL,
0.633 mmol) for 30 min, followed by addition of a solution of iodide 7
(100 mg, 0.317 mmol) in THF (1 mL) and [Pd2ACHTNUTRGNE(UGN dba)3]·CHCl3 (7.2 mg,
7.91ꢆ10À3 mmol), afforded compound 11-D-1 (72.7 mg, 80%, >95% 11-
1
D as determined by H NMR spectroscopy).
Synthesis of trans-12-deuteroretinol (12-D-1): Following the general pro-
cedure, treatment of
a solution of dienylsilane 4-D-13 (117 mg,
0.474 mmol) in THF (1 mL) with TBAF·3H2O (1.0m in THF, 632 mL,
0.633 mmol) for 30 min, followed by addition of a solution of iodide 7
(100 mg, 0.317 mmol) in THF (1 mL) and [Pd2ACHTNUTRGNE(UGN dba)3]·CHCl3 (7.2 mg,
7.91ꢆ10À3 mmol), afforded compound 12-D-1 (74.5 mg, 82%, >95% 12-
1
D as determined by H NMR spectroscopy).
Synthesis of trans-11,12-dideuteroretinol (11,12-D2-1): Following the gen-
eral procedure, treatment of a solution of dienylsilane 4,5-D2-13 (170 mg,
0.683 mmol) in THF (1 mL) with TBAF·3H2O (1.0m in THF, 911 mL,
0.911 mmol) for 30 min, followed by addition of a solution of iodine 7
(144 mg, 0.455 mmol) in THF (1 mL) and [Pd2ACHTNUTRGNE(UNG dba)3]·CHCl3 (10.4 mg,
1.14ꢆ10À2 mmol), afforded compound 11,12-D2-1 (103 mg, 78%,>95%
1
11,12-D2 as determined by H NMR spectroscopy).
&
6
&
ꢃ 2012 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Chem. Eur. J. 0000, 00, 0 – 0
ÝÝ
These are not the final page numbers!